Abraham Carboo

Abraham Carboo

Auto-generated profile, based on publicly available information

Abraham Carboo

Department of Medicine, Yale-Waterbury Hospital, Waterbury, Connecticut, United States

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
PKPatrick Amanning Kwaah
Patrick Amanning Kwaah
SMSamuel A. Mensah
Samuel A. Mensah
ACAbraham Carboo
Abraham Carboo
GAGrace Appah
Grace Appah
HRHamza A. Rashid
Hamza A. Rashid
CSChristopher B. Sarpong
Christopher B. Sarpong
Chronic ischemic heart disease (CIHD) is one of the leading causes of significant morbidity and mortality in the United States. While previous studies have reported an overall decline in ischemic heart disease mortality, contemporary trends in CIHD-related mortality across sex, race, and urbanization status remain inadequately explored. We examined CIHD-related mortality trends in the U.S. from 1999 to 2019.We analyzed mortality data from the CDC WONDER database using CIHD ICD-10 codes. Age-adjusted mortality rates (AAMR) were calculated per 100,000 individuals. Trends were analyzed using Joinpoint regression to determine annual percentage change (APC) and average annual percentage change (AAPC) with 95% confidence intervals. Over two decades, 5,729,619 CIHD-related deaths were recorded. AAMR declined from 185.6 (95% CI: 184.9–186.2) per 100,000 in 1999 to 94.9 (95% CI: 94.5–95.3) per 100,000 in 2019. There were, however, disparities among demographic groups. Males had consistently higher mortality than females (overall AAMR: 167.2 vs. 96.0 per 100,000), and among racial groups, non-Hispanic Black individuals had the highest AAMR (148.3 per 100,000. Initially, urban areas had higher mortality than rural areas, but by 2019, their AAMRs converged (urban: 94.7 [95% CI: 94.3–95.1]; rural: 96.1 [95% CI: 95.1–97.0] per 100,000). CIHD mortality has declined across all demographics over the last two decades; however, disparities persist, particularly among males and non-Hispanic Black individuals. While rural and urban populations had differing mortality rates initially, they showed similar AAMR by the end of the study period. Focused public health interventions are crucial to addressing these inequities.

1 January 2026 in Journal of Cardiovascular Intervention
Verified
Journal Article
Open access
PDF file
EEEkow Essien
Ekow Essien
AAAbena Agyekum
Abena Agyekum
ACAbraham Carboo
Abraham Carboo
GAGloria Amoako
Gloria Amoako
KNKarldon Nwaezeapu
Karldon Nwaezeapu
GAGodbless Ajenaghughrure
Godbless Ajenaghughrure
Essien E, et al. J Cardiovasc Interv. 2025 Aug;5:e2. https://doi.org/10.54912/jci.2025.0029

1 October 2025 in ACG Case Reports Journal
Verified
Journal Article
Open access
ACAbraham Carboo
Abraham Carboo
MRMohammad Ramadan
Mohammad Ramadan
PKPatrick Kwaah
Patrick Kwaah
PDPia Dogbey
Pia Dogbey
Gastroduodenal artery pseudoaneurysm is an uncommon but life-threatening complication of acute pancreatitis (AP). We present a 58-year-old man with presumed mild AP who developed massive intra-abdominal hemorrhage due to a gastroduodenal artery pseudoaneurysm. The patient's initial imaging suggested a pancreatic pseudocyst, but an atypical presentation for AP prompted a computed tomography angiogram that identified an actively bleeding pseudoaneurysm. He underwent urgent coil embolization with successful hemorrhage control. This case highlights the importance of early recognition and multidisciplinary management of visceral artery pseudoaneurysms in pancreatitis to prevent potentially catastrophic outcomes.

1 June 2026 in Sleep Science
Verified
Journal Article
Open access
EEEkow Essien
Ekow Essien
AAAbena Agyekum
Abena Agyekum
ACAbraham Carboo
Abraham Carboo
GAGloria Amoako
Gloria Amoako
JOJustice Owusu-Achiaw
Justice Owusu-Achiaw
SGSamuel Bisilki Governor
Samuel Bisilki Governor
Obstructive sleep apnea (OSA) increases cardiovascular disease risk through systemic inflammation, particularly through elevated C-reactive protein (CRP). This study investigated whether CRP stratification predicts mortality and cardiovascular events in OSA patients. We conducted a retrospective cohort analysis using the TriNetX Research Network, encompassing electronic health records from 130 healthcare institutions. Adults (ages 18–90 years) with OSA were stratified by CRP concentration: elevated (≥ 3.0 mg/L) versus low (≤ 2.9 mg/L). After propensity score matching for demographics and comorbidities, 240,727 participants per cohort were followed for five years. Primary outcome was all-cause mortality; secondary outcomes included cardiovascular events, arrhythmias, and acute kidney injury. Elevated CRP was associated with significantly higher all-cause mortality (11.3% versus 7.0%; HR 1.695, 95% CI 1.662–1.727; p < 0.001). The elevated CRP group demonstrated heightened cardiovascular risk: cardiogenic shock (1.0% versus 0.5%; HR 2.003), heart failure (9.8% versus 6.5%; HR 1.594), pulmonary hypertension (4.9% versus 3.4%; HR 1.508), and acute kidney injury (11.0% versus 6.4%; HR 1.825), all p < 0.001. Arrhythmic complications were also increased: atrial fibrillation/flutter (6.3% versus 4.8%; HR 1.372) and ventricular tachycardia (2.3% versus 1.8%; HR 1.388), both p < 0.001. Elevated CRP constitutes a robust predictor of mortality and cardiovascular morbidity in OSA populations. Assessment of inflammatory biomarkers may enhance risk stratification, informing intensified monitoring and targeted therapeutic interventions.